D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.09% |
| 2 | Technology | 10.39% |
| 3 | Financials | 9.94% |
| 4 | Consumer Discretionary | 8.57% |
| 5 | Communication Services | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
S&T Bancorp
STBA
$1.86B
| $328K | ﹤0.01% |
+12,744
| New | +$334K |
|
|
BBBY
2952
CALL
DELISTED
Bed Bath & Beyond Inc
BBBY
| $328K | ﹤0.01% |
6,600
-39,000
| -86% | -$1.83M |
|
|
ZEUS
2953
DELISTED
Olympic Steel
ZEUS
| $327K | ﹤0.01% |
+18,878
| New | +$224K |
|
|
SUM
2954
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $326K | ﹤0.01% |
+17,507
| New | +$286K |
|
|
JMEI
2955
PUT
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
| $326K | ﹤0.01% |
5,000
+1,000
| +25% | +$64.5K |
|
|
FBNK
2956
DELISTED
First Connecticut Bancorp, Inc
FBNK
| $325K | ﹤0.01% |
20,346
-3,247
| -14% | -$52.7K |
|
2957
Hancock Whitney
HWC
$6.13B
| $324K | ﹤0.01% |
+14,115
| New | +$332K |
|
2958
CoStar Group
CSGP
$11.3B
| $323K | ﹤0.01% |
+17,160
| New | +$304K |
|
2959
Scholastic
SCHL
$796M
| $323K | ﹤0.01% |
+8,654
| New | +$308K |
|
2960
Center Bancorp
CNOB
$1.63B
| $321K | ﹤0.01% |
19,642
-4,576
| -19% | -$74.5K |
|
2961
Forrester Research
FORR
$172M
| $321K | ﹤0.01% |
9,561
-5,440
| -36% | -$168K |
|
2962
Immunic
IMUX
$182M
| $321K | ﹤0.01% |
88
+41
| +87% | +$142K |
|
2963
CALL
Capital One
COF
$124B
| $319K | ﹤0.01% |
4,600
-35,400
| -89% | -$2.34M |
|
2964
Jones Lang LaSalle
JLL
$15.1B
| $318K | ﹤0.01% |
+2,712
| New | +$329K |
|
2965
UBS Group
UBS
$170B
| $318K | ﹤0.01% |
19,845
+1,300
| +7% | +$21.1K |
|
2966
Chegg
CHGG
$108M
| $317K | ﹤0.01% |
71,168
+47,093
| +196% | +$239K |
|
|
EPAY
2967
DELISTED
Bottomline Technologies Inc
EPAY
| $317K | ﹤0.01% |
10,399
-7,901
| -43% | -$226K |
|
|
ELGX
2968
DELISTED
Endologix Inc
ELGX
| $317K | ﹤0.01% |
3,790
-5,165
| -58% | -$426K |
|
|
SBNY
2969
DELISTED
Signature Bank
SBNY
| $317K | ﹤0.01% |
2,326
-76,043
| -97% | -$10.4M |
|
2970
Cavco Industries
CVCO
$4.39B
| $316K | ﹤0.01% |
3,386
-10,185
| -75% | -$839K |
|
2971
Omnicom Group
OMC
$22.7B
| $316K | ﹤0.01% |
3,793
-65,986
| -95% | -$4.97M |
|
|
VASC
2972
DELISTED
Vascular Solutions Inc
VASC
| $315K | ﹤0.01% |
+9,680
| New | +$279K |
|
|
QIWI
2973
DELISTED
QIWI PLC
QIWI
| $315K | ﹤0.01% |
+21,772
| New | +$291K |
|
2974
Kadant
KAI
$3.69B
| $313K | ﹤0.01% |
6,933
-2,591
| -27% | -$103K |
|
2975
Tonix Pharmaceuticals
TNXP
$157M
| – | – |
0
| – | – |
|
Similar funds
D.E. Shaw & Co's Q1 2016 Portfolio in Review
As of Q1 2016, D.E. Shaw & Co held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
D.E. Shaw & Co withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, D.E. Shaw & Co opened a new position in EQT Corp worth $47.6M.
- D.E. Shaw & Co's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- D.E. Shaw & Co added most to Allergan plc in Q1 2016, an estimated $397M increase.
- D.E. Shaw & Co's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- D.E. Shaw & Co fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- D.E. Shaw & Co's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- D.E. Shaw & Co opened 382 new positions and closed 773 in Q1 2016.
- D.E. Shaw & Co's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.